ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC36147-100mg |
|
2230197-64-3 |
GLP-1 receptor agonist 2
|
0 | C30H31ClFN5O4 | |
GC36147-50mg |
|
2230197-64-3 |
GLP-1 receptor agonist 2
|
0 | C30H31ClFN5O4 | |
GC36147-25mg |
|
2230197-64-3 |
GLP-1 receptor agonist 2
|
0 | C30H31ClFN5O4 | |
GC36147-10mg |
|
2230197-64-3 |
GLP-1 receptor agonist 2
|
0 | C30H31ClFN5O4 | |
GC36147-5mg |
|
2230197-64-3 |
GLP-1 receptor agonist 2
|
0 | C30H31ClFN5O4 | |
GC36147-10mM (in 1mL DMSO) |
|
2230197-64-3 |
GLP-1 receptor agonist 2
|
0 | C30H31ClFN5O4 | |
GC36142-100mg |
|
1025015-40-0 |
GK921
|
0 | C21H20N4O | |
GC36142-50mg |
|
1025015-40-0 |
GK921
|
0 | C21H20N4O | |
GC36142-10mg |
|
1025015-40-0 |
GK921
|
0 | C21H20N4O | |
GC36142-5mg |
|
1025015-40-0 |
GK921
|
0 | C21H20N4O | |
GC36142-2mg |
|
1025015-40-0 |
GK921
|
0 | C21H20N4O | |
GC36142-10mM (in 1mL DMSO) |
|
1025015-40-0 |
GK921
|
0 | C21H20N4O | |
GC36140-5mg |
|
90985-77-6 |
Ginsenoside Ra3
|
0 | C59H100O27 | |
GC36140-1mg |
|
90985-77-6 |
Ginsenoside Ra3
|
0 | C59H100O27 | |
GC36137-5mg |
|
181225-33-2 |
Ginsenoside F4
|
0 | C42H70O12 | |
GC36137-1mg |
|
181225-33-2 |
Ginsenoside F4
|
0 | C42H70O12 | |
GC36136-5mg |
|
153355-70-5 |
Ginkgolide K
|
0 | C19H22O9 | |
GC36136-1mg |
|
153355-70-5 |
Ginkgolide K
|
0 | C19H22O9 | |
GC36135-100mg |
|
1254053-84-3 |
Gilteritinib hemifumarate
|
0 | C29H44N8O3 0.5C4H4O4 | |
GC36135-50mg |
|
1254053-84-3 |
Gilteritinib hemifumarate
|
0 | C29H44N8O3 0.5C4H4O4 | |